share_log

Finch Therapeutics Gr Q3 EPS $(1.51) Up From $(25.38) YoY

Finch Therapeutics Gr Q3 EPS $(1.51) Up From $(25.38) YoY

Finch Therapeutics Gr第三季度每股收益爲1.51美元,高於同比增長25.38美元
Benzinga ·  2023/11/08 06:35

Finch Therapeutics Gr (NASDAQ:FNCH) reported quarterly losses of $(1.51) per share. This is a 94.05 percent increase over losses of $(25.38) per share from the same period last year.

Finch Therapeutics Gr(納斯達克股票代碼:FNCH)公佈季度每股虧損1.51美元。這比去年同期每股虧損25.38美元(25.38美元)增加了94.05%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論